CN101379055B - 取代的喹诺酮类ⅲ - Google Patents

取代的喹诺酮类ⅲ Download PDF

Info

Publication number
CN101379055B
CN101379055B CN2007800049872A CN200780004987A CN101379055B CN 101379055 B CN101379055 B CN 101379055B CN 2007800049872 A CN2007800049872 A CN 2007800049872A CN 200780004987 A CN200780004987 A CN 200780004987A CN 101379055 B CN101379055 B CN 101379055B
Authority
CN
China
Prior art keywords
group
alkyl
compound
trifluoromethoxy
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007800049872A
Other languages
English (en)
Chinese (zh)
Other versions
CN101379055A (zh
Inventor
昌塔尔·菲尔斯特纳
凯·锡德
霍尔格·齐默曼
大卫·布吕克纳
克斯廷·亨宁格
迪特尔·朗
鲁道夫·舍夫赫-卢普
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aicuris GmbH and Co KG
Original Assignee
Aicuris GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris GmbH and Co KG filed Critical Aicuris GmbH and Co KG
Publication of CN101379055A publication Critical patent/CN101379055A/zh
Application granted granted Critical
Publication of CN101379055B publication Critical patent/CN101379055B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN2007800049872A 2006-02-09 2007-02-02 取代的喹诺酮类ⅲ Expired - Fee Related CN101379055B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006005861.5 2006-02-09
DE102006005861A DE102006005861A1 (de) 2006-02-09 2006-02-09 Substituierte Chinolone III
PCT/EP2007/000923 WO2007090579A2 (de) 2006-02-09 2007-02-02 Substituierte chinolone iii

Publications (2)

Publication Number Publication Date
CN101379055A CN101379055A (zh) 2009-03-04
CN101379055B true CN101379055B (zh) 2012-12-05

Family

ID=38283107

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800049872A Expired - Fee Related CN101379055B (zh) 2006-02-09 2007-02-02 取代的喹诺酮类ⅲ

Country Status (27)

Country Link
US (1) US7977349B2 (https=)
EP (1) EP1994020B1 (https=)
JP (1) JP5198291B2 (https=)
KR (1) KR101400568B1 (https=)
CN (1) CN101379055B (https=)
AR (1) AR059417A1 (https=)
AT (1) ATE513826T1 (https=)
AU (1) AU2007214006B2 (https=)
BR (1) BRPI0706988A2 (https=)
CA (1) CA2637204C (https=)
CY (1) CY1111805T1 (https=)
DE (1) DE102006005861A1 (https=)
DK (1) DK1994020T3 (https=)
DO (1) DOP2007000027A (https=)
ES (1) ES2366970T3 (https=)
IL (1) IL192662A (https=)
MY (1) MY151590A (https=)
PE (1) PE20080113A1 (https=)
PL (1) PL1994020T3 (https=)
PT (1) PT1994020E (https=)
RU (1) RU2433125C2 (https=)
SI (1) SI1994020T1 (https=)
TW (1) TWI382980B (https=)
UA (1) UA94934C2 (https=)
UY (1) UY30135A1 (https=)
WO (1) WO2007090579A2 (https=)
ZA (1) ZA200806355B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059339A1 (es) * 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
TW200811153A (en) 2006-06-23 2008-03-01 Japan Tobacco Inc 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor
DE102011101446A1 (de) 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
EP3558992A4 (en) 2016-12-15 2020-12-02 ONO Pharmaceutical Co., Ltd. TREK CHANNEL ACTIVATOR (K + CHANNELS ASSOCIATED WITH TWIK)
JP7403472B2 (ja) 2018-05-09 2023-12-22 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規キノリン誘導体

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB932487A (en) 1960-07-25 1963-07-31 D G Searle & Co Piperidine derivatives
DE3420743A1 (de) 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DK164287A (da) 1986-03-31 1987-10-01 Sankyo Co Quinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf og deres anvendelse
DE3702393A1 (de) 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
AU618823B2 (en) 1988-07-20 1992-01-09 Sankyo Company Limited 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
US4959363A (en) 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
DE4303657A1 (de) 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate
KR0169500B1 (ko) * 1993-08-13 1999-01-15 이우용 새로운 퀴놀론 카르복실산 유도체 및 그의 제조방법
FR2713116B1 (fr) 1993-11-30 1996-01-12 Techmetal Promotion Dispositif d'alimentation pour le dépôt par simple gravité d'un matériau granuleux sur la surface d'un métal liquide coulé en continu.
KR960004339A (ko) 1994-07-02 1996-02-23 임성기 신규한 퀴놀린계 화합물 및 그 의 제조방법
AU696390B2 (en) 1995-08-02 1998-09-10 Darwin Discovery Limited Quinolones and their therapeutic use
DE69631423T2 (de) 1995-08-02 2004-12-02 Darwin Discovery Ltd., Slough Chinolone und deren therapeutische verwendung
DE69840599D1 (de) * 1997-09-15 2009-04-09 Procter & Gamble Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
US6248739B1 (en) * 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
DE19937024A1 (de) 1999-08-05 2001-02-08 Bayer Ag Verwendung von Acylsulfonamido substituierten Polymethin-Farbstoffen als Fluoreszenz-Farbstoffe und/oder Marker
US6525049B2 (en) * 2000-07-05 2003-02-25 Pharmacia & Upjohn Company Pyrroloquinolones as antiviral agents
AU2001280091A1 (en) 2000-08-01 2002-02-13 Wockhardt Limited Inhibitors of cellular efflux pumps of microbes
GB0023918D0 (en) 2000-09-29 2000-11-15 King S College London Antiparasitic compounds
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
AU2002361493A1 (en) 2001-12-13 2003-06-23 Wockhardt Limited New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
EP1610759A4 (en) 2003-04-07 2007-04-25 Cylene Pharmaceuticals Inc SUBSTITUTED CHINOBENZOXAZINE ANALOGUE
WO2005049602A1 (en) * 2003-11-18 2005-06-02 Warner-Lambert Company Llc Quinolone antibacterial agents
DE102004035203A1 (de) 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone
DE102005030524A1 (de) 2005-06-30 2007-01-18 Aicuris Gmbh & Co. Kg Substituierte Chinolone II

Also Published As

Publication number Publication date
EP1994020A2 (de) 2008-11-26
DK1994020T3 (da) 2011-09-19
WO2007090579A3 (de) 2007-11-15
KR101400568B1 (ko) 2014-05-26
PT1994020E (pt) 2011-09-02
RU2433125C2 (ru) 2011-11-10
EP1994020B1 (de) 2011-06-22
DE102006005861A1 (de) 2007-08-23
JP5198291B2 (ja) 2013-05-15
KR20080100248A (ko) 2008-11-14
PL1994020T3 (pl) 2011-10-31
HK1125372A1 (zh) 2009-08-07
RU2008136079A (ru) 2010-03-20
BRPI0706988A2 (pt) 2011-04-19
TWI382980B (zh) 2013-01-21
ATE513826T1 (de) 2011-07-15
AR059417A1 (es) 2008-04-09
ZA200806355B (en) 2010-02-24
JP2009525999A (ja) 2009-07-16
AU2007214006B2 (en) 2011-11-03
WO2007090579A2 (de) 2007-08-16
UY30135A1 (es) 2007-09-28
US20090181996A1 (en) 2009-07-16
SI1994020T1 (sl) 2011-10-28
IL192662A (en) 2013-04-30
MY151590A (en) 2014-06-13
CY1111805T1 (el) 2015-10-07
AU2007214006A1 (en) 2007-08-16
TW200808757A (en) 2008-02-16
CN101379055A (zh) 2009-03-04
CA2637204C (en) 2013-04-16
ES2366970T3 (es) 2011-10-27
DOP2007000027A (es) 2007-10-31
UA94934C2 (uk) 2011-06-25
IL192662A0 (en) 2009-08-03
PE20080113A1 (es) 2008-04-18
US7977349B2 (en) 2011-07-12
CA2637204A1 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
JP6896113B2 (ja) ジアザ二環式置換イミダゾピリミジンおよび呼吸障害を治療するためのその使用
JP4816828B2 (ja) ソリフェナシン非晶質体を含有した固形医薬組成物
TW201734012A (zh) 經取代2-苯基-3-(哌甲基)咪唑并吡啶類及其用途
TW201808293A (zh) 經取代之二氮雜雙環化合物及其用途
CN101379055B (zh) 取代的喹诺酮类ⅲ
TW200845998A (en) Heterocyclic compounds useful in treating diseases and conditions
TW201625618A (zh) 抑制瞬時受體電位a1離子通道
CN105873919A (zh) 作为类糜蛋白酶抑制剂的取代的尿嘧啶
WO2017153958A1 (en) Novel polymorphic forms and amorphous form of olaparib
WO2013124385A2 (en) Solid forms of dabigatran etexilate mesylate and processes for their preparation
TW201920160A (zh) 2-(5-(4-(2-嗎啉乙氧基)苯基)吡啶-2-基)-n-芐乙醯胺之固態形式
JP5068648B2 (ja) 置換キノロン類
CN1980925B (zh) 具有抗病毒活性的取代的氮杂喹唑啉
TWI257389B (en) Pharmaceutical compound
AU769232B2 (en) Heterocyclic derivatives
JP5103392B2 (ja) 置換キノロン類ii
CN110267661A (zh) 包括trh类似物和丙基辛酸的组合的组合物和丙基辛酸的药学上可接受的盐
TW200803856A (en) Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
TWI313602B (en) Gyrase inhibitors and uses thereof
TW200813005A (en) Hydrate for pharmaceutical compositions
JPH0331719B2 (https=)
MX2008010198A (en) Substituted quinolones iii
JPWO1996022988A1 (ja) キノリンカルボン酸誘導体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20190108

Address after: Germany Wuppertal

Patentee after: AICURIS GMBH

Address before: Germany Wuppertal

Patentee before: Aicuris GmbH & Co. KG

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121205

Termination date: 20210202

CF01 Termination of patent right due to non-payment of annual fee